JP Morgan Maintains Overweight on Molina Healthcare, Raises Price Target to $392
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Calvin Sternick has maintained an Overweight rating on Molina Healthcare (NYSE:MOH) and increased the price target from $367 to $392.
November 17, 2023 | 3:33 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
JP Morgan analyst Calvin Sternick reaffirmed an Overweight rating on Molina Healthcare and raised the price target to $392.
The increase in price target by a reputable analyst like Calvin Sternick from JP Morgan is a strong positive signal for investors, suggesting a bullish outlook on the stock. This can lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100